Antiangiogenic mechanisms of diet-derived polyphenols

Journal of Nutritional Biochemistry

Volumn 13, Issue 7, 2002, Pages 380-390

  Cao, Yihai ^a   Cao, Renhai ^a   Bråkenhielm, Ebba ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Angiogenesis; EGCG; Flavonoids; Resveratrol; Tumor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; APIGENIN; BAICALEIN; CATECHIN; CYCLIN DEPENDENT KINASE; DAIDZEIN; ENDOSTATIN; ENDOTHELIN 1; ESTROGEN; FISETIN; FLAVONOL; FREE RADICAL; HYALURONIDASE; ISOFLAVONE DERIVATIVE; LUTEOLIN; MATRIX METALLOPROTEINASE; MYRICETIN; NITRIC OXIDE SYNTHASE; POLYPHENOL; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANGIOGENESIS; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CHEMOPROPHYLAXIS; DIABETIC RETINOPATHY; DIET; ENDOTHELIUM CELL; HEART DISEASE; HUMAN; METASTASIS; NONHUMAN; PLANT; RABBIT; REVIEW; RISK; TUMOR GROWTH;

ANIMALIA;

EID: 0036305189     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00204-8     Document Type: Review

References (116)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. Strategies for discovering drugs from previously unexplored natural products
4. Natural products in drug discovery and development
5. A review of latest research findings on the health promotion properties of tea
6. Potent inhibitory action of red wine polyphenols on human breast cancer cells
7. Certain aspects of molecular endocrinology that relate to the influence of dietary factors on the pathogenesis of prostate cancer
8. Do wine polyphenols modulate p53 gene expression in human cancer cell lines?
9. Inhibition of carcinogenesis by dietary polyphenolic compounds
10. Endogenous angiogenesis inhibitors and their therapeutic implications
11. Endogenous angiogenesis inhibitors; angiostatin, endostatin, and other proteolytic fragments
12. The preclinical evaluation of angiogenesis inhibitors
13. Tumor angiogenesis; therapeutic implications
14. Tumor growth and neovascularization; an experimental model using the rabbit cornea
15. Vascular endothelial growth factor C induces angiogenesis in vivo
16. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers
17. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells; regulation of cyclin-dependent kinases CDK2 and CDK1
18. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands
19. Health effects and bioavailability of dietary flavonols
20. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis
21. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis
22. Vegetarian diet; panacea for modern lifestyle diseases?
23. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors
24. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis
25. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes
26. Angiogenesis inhibited by drinking tea
27. Evaluation of the biochemical targets of genistein in tumor cells
28. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism
29. Tumor invasion; molecular shears blunted by green tea
30. Angioprevention; angiogenesis is a common and key target for cancer chemopreventive agents
31. Tea and tea polyphenols in cancer prevention
32. The chemistry of tea flavonoids
33. Green tea and the risk of gastric cancer in Japan
34. (-)Epigallocatechin-3-gallate inhibits leukocyte elastase; potential of the phyto-factor in hindering inflammation, emphysema, and invasion
35. Why drinking green tea could prevent cancer
36. Polyphenols as inhibitors of carcinogenesis
37. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea
38. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation
39. Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator
40. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate
41. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
42. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade
43. Mortality associated with moderate intakes of wine, beer, or spirits
44. Wine, alcohol, platelets, and the French paradox for coronary heart disease
45. Does diet or alcohol explain the French paradox?
46. Red wine, tea, and antioxidants
47. Endothelin-1 synthesis reduced by red wine
48. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine
49. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats
50. An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine
51. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats
52. Plasma and tissue resveratrol concentrations and pharmacological activity
53. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes
54. Antiplatelet activity of synthetic and natural resveratrol in red wine
55. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro
56. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor
57. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase
58. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats
59. Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin
60. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2
61. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells
62. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
63. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage
64. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells
65. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice
66. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
67. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells
68. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures
69. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity
70. Dietary supplementation with the anti-tumour promoter quercetin; its effects on matrix metalloproteinase gene regulation
71. Induction of apoptosis by quercetin; involvement of heat shock protein
72. Effects of daily oral administration of quercetin chalcone and modified citrus pectin
73. Resveratrol and quercetin inhibit angiogenesis in vitro
74. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer
75. Soy intake and cancer risk; a review of the in vitro and in vivo data
76. Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids
77. Phytoestrogens and inhibition of angiogenesis
78. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis
79. Genistein, a specific inhibitor of tyrosine-specific protein kinases
80. Growth inhibition of human breast cancer cells by herbs and phytoestrogens
81. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice
82. Effect of flavonoids on cell cycle progression in prostate cancer cells
83. Effect of genistein on in vitro and in vivo models of cancer
84. Genistein, a dietary-derived inhibitor of in vitro angiogenesis
85. [Inhibition of neovascularization of the eye by dietary factors exemplified by isoflavonoids]
86. Comment, Clinical development plan; genistein
87. Controlling the vasculature; angiogenesis, anti-angiogenesis and vascular targeting of gene therapy
88. Genistein exerts multiple suppressive effects on human breast carcinoma cells
89. Apigenin inhibits endothelial-cell proliferation in G(2)/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression
90. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid
91. Influence of vehicle, distant topical delivery, and biotransformation on the chemopreventive activity of apigenin, a plant flavonoid, in mouse skin
92. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice
93. Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol
94. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin
95. Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats
96. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO)
97. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor
98. Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor
99. Effect of flavonoids on daunomycin-induced toxicity in cultivated endothelial cells
100. Suppression of TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells
101. Pharmacological effects of urinary products obtained after treatment with saiboku-to, a herbal medicine for bronchial asthma, on type IV allergic reaction
102. The herbal medicine sho-saiko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases
103. Polyphenols of cocoa; inhibition of mammalian 15-lipoxygenase
104. Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules
105. Endothelium-dependent contraction and direct relaxation induced by baicalein in rat mesenteric artery
106. Two high-performance liquid chromatographic assays for the determination of free and total silibinin diastereomers in plasma using column switching with electrochemical detection and reversed-phase chromatography with ultraviolet detection
107. Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin
108. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes; implications in cancer chemoprevention
109. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells; implications for prostate cancer intervention
110. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model
111. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin; inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells
112. Looking for a good endothelial address
113. Novel small molecule alpha v integrin antagonists; comparative anti-cancer efficacy with known angiogenesis inhibitors
114. Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cells
115. Review of three new agents that target angiogenesis, matrix metalloproteinases, and cyclin-dependent kinases